NZ Dermatology Research Review Issue 19

In this issue:

Afamelanotide for erythropoietic protoporphyria
Cysteamine 5% cream improves epidermal melasma
Oral corticosteroid minipulse vs low-dose oral MTX in vitiligo
Hyperkalaemia isn’t likely with spironolactone for acne
Infection risk with psoriasis treatments
Secukinumab vs ustekinumab in psoriasis
Ustekinumab in adolescents with psoriasis
Basal cell carcinoma on sun protected vs exposed skin
Skin cancer risk with antihypertensive drugs
Waikato Teledermatology report

Please login below to download this issue (PDF)